Ascorbate insufficiency disrupts glutamatergic signaling and alters electroencephalogram phenotypes in a mouse model of Alzheimer's disease

IF 5.1 2区 医学 Q1 NEUROSCIENCES Neurobiology of Disease Pub Date : 2024-07-13 DOI:10.1016/j.nbd.2024.106602
Rebecca A. Buchanan , Yuhan Wang , James M. May , Fiona E. Harrison
{"title":"Ascorbate insufficiency disrupts glutamatergic signaling and alters electroencephalogram phenotypes in a mouse model of Alzheimer's disease","authors":"Rebecca A. Buchanan ,&nbsp;Yuhan Wang ,&nbsp;James M. May ,&nbsp;Fiona E. Harrison","doi":"10.1016/j.nbd.2024.106602","DOIUrl":null,"url":null,"abstract":"<div><p>Clinical studies have reported that increased epileptiform and subclinical epileptiform activity can be detected in many patients with an Alzheimer's disease (AD) diagnosis using electroencephalogram (EEG) and this may correlate with poorer cognition. Ascorbate may have a specific role as a neuromodulator in AD as it is released concomitantly with glutamate reuptake following excitatory neurotransmission. Insufficiency may therefore result in an exacerbated excitatory/inhibitory imbalance in neuronal signaling. Using a mouse model of AD that requires dietary ascorbate (Gulo<sup>−/-</sup>APP<sup>swe</sup>/PSEN1<sup>dE9</sup>), EEG was recorded at baseline and during 4 weeks of ascorbate depletion in young (5-month-old) and aged (20-month-old) animals. Data were scored for changes in quantity of spike trains, individual spikes, sleep-wake rhythms, sleep fragmentation, and brainwave power bands during light periods each week. We found an early increase in neuronal spike discharges with age and following ascorbate depletion in AD model mice and not controls, which did not correlate with brain amyloid load. Our data also show more sleep fragmentation with age and with ascorbate depletion. Additionally, changes in brain wave activity were observed within different vigilance states in both young and aged mice, where Gulo<sup>−/-</sup>APP<sup>swe</sup>/PSEN1<sup>dE9</sup> mice had shifts towards higher frequency bands (alpha, beta, and gamma) and ascorbate depletion resulted in shifts towards lower frequency bands (delta and theta). Microarray data supported ascorbate insufficiency altering glutamatergic transmission through the decreased expression of glutamate related genes, however no changes in protein expression of glutamate reuptake transporters were observed. These data suggest that maintaining optimal brain ascorbate levels may support normal brain electrical activity and sleep patterns, particularly in AD patient populations where disruptions are observed.</p></div>","PeriodicalId":19097,"journal":{"name":"Neurobiology of Disease","volume":null,"pages":null},"PeriodicalIF":5.1000,"publicationDate":"2024-07-13","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.sciencedirect.com/science/article/pii/S096999612400202X/pdfft?md5=0f1e6ba281d2651886d9c019045a2aa4&pid=1-s2.0-S096999612400202X-main.pdf","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Neurobiology of Disease","FirstCategoryId":"3","ListUrlMain":"https://www.sciencedirect.com/science/article/pii/S096999612400202X","RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q1","JCRName":"NEUROSCIENCES","Score":null,"Total":0}
引用次数: 0

Abstract

Clinical studies have reported that increased epileptiform and subclinical epileptiform activity can be detected in many patients with an Alzheimer's disease (AD) diagnosis using electroencephalogram (EEG) and this may correlate with poorer cognition. Ascorbate may have a specific role as a neuromodulator in AD as it is released concomitantly with glutamate reuptake following excitatory neurotransmission. Insufficiency may therefore result in an exacerbated excitatory/inhibitory imbalance in neuronal signaling. Using a mouse model of AD that requires dietary ascorbate (Gulo−/-APPswe/PSEN1dE9), EEG was recorded at baseline and during 4 weeks of ascorbate depletion in young (5-month-old) and aged (20-month-old) animals. Data were scored for changes in quantity of spike trains, individual spikes, sleep-wake rhythms, sleep fragmentation, and brainwave power bands during light periods each week. We found an early increase in neuronal spike discharges with age and following ascorbate depletion in AD model mice and not controls, which did not correlate with brain amyloid load. Our data also show more sleep fragmentation with age and with ascorbate depletion. Additionally, changes in brain wave activity were observed within different vigilance states in both young and aged mice, where Gulo−/-APPswe/PSEN1dE9 mice had shifts towards higher frequency bands (alpha, beta, and gamma) and ascorbate depletion resulted in shifts towards lower frequency bands (delta and theta). Microarray data supported ascorbate insufficiency altering glutamatergic transmission through the decreased expression of glutamate related genes, however no changes in protein expression of glutamate reuptake transporters were observed. These data suggest that maintaining optimal brain ascorbate levels may support normal brain electrical activity and sleep patterns, particularly in AD patient populations where disruptions are observed.

查看原文
分享 分享
微信好友 朋友圈 QQ好友 复制链接
本刊更多论文
抗坏血酸不足会破坏谷氨酸能信号传导并改变阿尔茨海默病小鼠模型的脑电图表型
临床研究报告称,许多阿尔茨海默病(AD)患者通过脑电图(EEG)可发现癫痫样和亚临床癫痫样活动增加,这可能与认知能力较差有关。抗坏血酸作为一种神经调节剂在阿尔茨海默病中可能具有特殊作用,因为它在兴奋性神经传递后与谷氨酸再摄取同时释放。因此,缺乏抗坏血酸可能会导致神经元信号传导中兴奋/抑制失衡加剧。利用需要从食物中摄取抗坏血酸的 AD 小鼠模型(Gulo-/-APPswe/PSEN1dE9),记录了幼鼠(5 个月大)和老 鼠(20 个月大)在基线和抗坏血酸缺乏 4 周期间的脑电图。对每周光照期间尖峰序列数量、单个尖峰、睡眠-觉醒节律、睡眠片段和脑电波功率波段的变化进行数据评分。我们发现,随着年龄的增长和抗坏血酸的消耗,AD 模型小鼠的神经元尖峰放电会出现早期增加,而对照组则不会,这与大脑淀粉样蛋白负荷并不相关。我们的数据还显示,随着年龄的增长和抗坏血酸的消耗,睡眠片段化程度更高。此外,在年轻小鼠和老年小鼠的不同警觉状态下都观察到了脑电波活动的变化,Gulo/-APPswe/PSEN1dE9小鼠的脑电波向高频段(α、β和γ)转移,而抗坏血酸消耗则导致向低频段(δ和θ)转移。微阵列数据支持抗坏血酸不足会通过谷氨酸相关基因表达的减少来改变谷氨酸能传导,但未观察到谷氨酸再摄取转运体蛋白表达的变化。这些数据表明,保持大脑最佳的抗坏血酸水平可支持正常的脑电活动和睡眠模式,尤其是在观察到脑电活动和睡眠模式紊乱的注意力缺失症患者群体中。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 去求助
来源期刊
Neurobiology of Disease
Neurobiology of Disease 医学-神经科学
CiteScore
11.20
自引率
3.30%
发文量
270
审稿时长
76 days
期刊介绍: Neurobiology of Disease is a major international journal at the interface between basic and clinical neuroscience. The journal provides a forum for the publication of top quality research papers on: molecular and cellular definitions of disease mechanisms, the neural systems and underpinning behavioral disorders, the genetics of inherited neurological and psychiatric diseases, nervous system aging, and findings relevant to the development of new therapies.
期刊最新文献
Low-beta versus high-beta band cortico-subcortical coherence in movement inhibition and expectation. TNFα prevents FGF4-mediated rescue of astrocyte dysfunction and reactivity in human ALS models. Legumain/asparaginyl endopeptidase-resistant tau fibril fold produces corticobasal degeneration-specific C-terminal tau fragment. Striatal cholinergic transmission in an inducible transgenic mouse model of paroxysmal non-kinesiogenic dyskinesia. Direct conversion of human umbilical cord mesenchymal stem cells into dopaminergic neurons for Parkinson's disease treatment.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
已复制链接
已复制链接
快去分享给好友吧!
我知道了
×
扫码分享
扫码分享
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1